pr-inside.com
Print

Research and Markets: Pharmaceutical Industry in Brazil



2009-11-10 20:01:10 -

Research and Markets ( www.researchandmarkets.com/research/83a629/pharmaceutical_ind : cts.businesswire.com/ct/CT?id=smartlink&url=http%3A%2F%2Fwww .. ) has announced the addition of the " Pharmaceutical Industry in Brazil : cts.businesswire.com/ct/CT?id=smartlink&url=http%3A%2F%2Fwww .. " report to their offering.

The birth origins of the Pharmaceutical Industry can be traced back to more humble antecedents than just chemistry labs. The earliest incidents of recognition of the antiseptic properties of the dyestuffs is around the late

19th century. The invention of penicillin can yet be recognized as a major milestone for the emergent industry which firmly consolidated its R&D efforts in the 1950's. Further in the 1960's the patent regulation support gave a further impetus to the industry in new discoveries and relaxed controls on clinical development with the booming spend on healthcare as economies boomed globally.

The global presence of the pharmaceutical industry is evident with the roll out of continent specific R&D programs and drugs which help companies maximize penetration of markets and garner increased revenues with intercontinental treatment demand of patients being serviced from often one or two mega research centers in the continent.

The pharmaceutical industry is under mounting scrutiny because of rapidly increasing expenditures for drugs worldwide. Drug expenditures are now the fastest-growing component of health care costs, increasing at the rate of about 15 percent per year. They account for about eight percent of health care spending, and at their current rate of increase, they will soon surpass spending for physicians' services and, for many health care organizations, the costs of hospitalization.

Aruvian's R'search brings you a complete analysis of the Pharmaceutical Industry in Brazil : cts.businesswire.com/ct/CT?id=smartlink&url=http%3A%2F%2Fwww .. . The report covers a brief profile of the global pharmaceutical industry, the TRIPS agreement, offshoring in the pharmaceutical industry, economic trends in the industry, competition in the industry, and the key players in the pharmaceutical industry in Brazil - complete with a SWOT analysis of the leading companies in the market.


Key Topics Covered:

- A. Executive Summary
- B. The Global Pharmaceutical Industry - A Brief Profile
- C. TRIPS and the Global Pharmaceutical Industry
- D. Pharmaceutical Industry in Brazil : cts.businesswire.com/ct/CT?id=smartlink&url=http%3A%2F%2Fwww ..
- E. Competition in the Industry
- F. Leading Players in the Market
- G. Appendix
- H. Glossary of Terms

Companies Mentioned.

- Novartis AG
- GlaxoSmithKline Plc
- Pfizer Inc
- EMS Sigma Pharma Group


For more information visit www.researchandmarkets.com/research/83a629/pharmaceutical_ind : cts.businesswire.com/ct/CT?id=smartlink&url=http%3A%2F%2Fwww ..



Research and MarketsLaura Wood, Senior Manager, press@researchandmarkets.com : mailto:press@researchandmarkets.com U.S.

Fax: 646-607-1907Fax (outside U.S.): +353-1-481-1716

Author:
Hossam Abdel-Kader
e-mail
Web: http://www.pr-inside.com/
Telefon: +43 1 9582319




Disclaimer: If you have any questions regarding information in these press releases please contact the company added in the press release. Please do not contact pr-inside. We will not be able to assist you. PR-inside disclaims contents contained in this release.